Table 4.
Pharmacodynamic and pharmacokinetic characteristics and dosing of antibiotics commonly used in the ICU.
| Antibiotic | Pharmacodynamic | Pharmacokinetics | Dosing (with normal hepatic and renal function) |
|---|---|---|---|
| Piperacillin/tazobactam | T > MIC | Hydrophilic, renal clearance | 4.5 g every 6 h |
| Ceftazidime | T > MIC | Hydrophilic, renal clearance | 6 g every 24 h |
| Cefepime | T > MIC | Hydrophilic, renal clearance | 2 g every 8 h |
| Aztreonam | T > MIC | Hydrophilic, renal clearance | 1 g (2 g) every 8 h |
| Meropenem | T > MIC | Renal clearance | 1 g (2 g) every 8 h |
| Tigecycline | AUC/MIC | Hepatic and renal clearance | 100–200 mg loading dose, then 50–100 mg every 12 h |
| entamicin | Cmax/MIC | Hydrophilic, renal clearance | 7 mg/kg/day every 24 h |
| Amikacin | Cmax/MIC | Hydrophilic, renal clearance | 25–30 mg/kg/day every 24 h |
| Colistin | AUC/MIC | Hydrophilic, renal clearance | 9 MU loading dose, then 4.5 MU every 8–12 h |
| Fosfomycin | AU/MIC for Gram negatives, T > MIC for Gram Positives | Hydrophilic, hepatic clearance | 4–6 g every 6 h CI |
| Vancomycin | AUC/MIC | Renal clearance | 15–30 mg/kg loading dose, then 30–60 mg/kg every 12 h |
| Linezolid | AUC/MIC | Lipophilic, hepatic clearance | 600 mg every 12 h |
| eftaroline | T > MIC | Hydrophilic, renal clearance | 600 mg q12 h, IV |
| Ceftobiprole | T > MIC | Hydrophilic, renal clearance | 500 mg q8 h IV |
| Ceftazidime/avibactam | T > MIC | Hydrophilic, renal clearance | 2.5 g q8 h IV |
| Ceftolozane/tazobactam | T > MIC | Hydrophilic, renal clearance | 1.5 g q8 h/3 g q8 h |
| Meropenem/vaborbactam | T > MIC | Hydrophilic, renal clearance | 2 g/2 g q8 h |
AUC: Area under the receiver operating characteristic curve; ICUs: Intensive care units; IV: Intravenousinjection; MIC: Minimum inhibitor concentration; T: Time.